HOUSTON, TX--(Marketwired - Nov 4, 2015) - The Special Committee of the Board of Directors (the "Special Committee") of Nobilis Health Corp. (
"Yesterday, the Special Committee released the findings of the independent review it commissioned to investigate the allegations of the short-selling anonymous blogger (the "Hopper-Davis Report"). The Hopper-Davis Report concluded that '...the allegations are false, misleading, or without foundation.' The Company believes that Nobilis and its shareholders are the victims of a scheme to 'short and distort' and manipulate Nobilis's stock," said Matthew Maruca, the Company's General Counsel, "and the independent Special Committee not only supports, but also encourages, the Company's management's actions to protect both."
"These manipulative actions have caused the Company and the Company's shareholders to unfairly suffer losses. These losses will be redressed through legal and regulatory processes, and the Company will take immediate and aggressive action to protect the Company and the Company's shareholders," said Mr. Maruca.
The Hopper-Davis Report is available without modification and in its entirety, on Nobilis' website (http://www.nobilishealth.com/) under the "Investors" tab, and will be filed with securities regulators on SEDAR and EDGAR.
About Nobilis Health Corp.
Nobilis Health Corp. owns and manages ambulatory and acute care facilities to deliver innovative surgical healthcare services. Our focus is on improving access to care and patient outcomes by providing minimally invasive procedures that can be performed in low-cost, outpatient settings. We utilize innovative direct-to-patient marketing strategies and a proprietary technology platform to drive patient engagement. Currently, Nobilis owns and manages four surgical hospitals and five ASCs, partners with an additional 28 facilities throughout the country, and markets six independent brands.
Forward-Looking Statements
This news release may contain forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of Nobilis Health Corp. (the "Company") and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions and may discuss future expectations, contain projections of future results of operations or of financial condition, or state other forward-looking information. These statements are based on the Company's expectations, estimates, forecasts and projections and while the Company considers these to be reasonable based on information currently available, they may prove to be incorrect. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. These risks and uncertainties are discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com and in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2014, filed on April 2, 2015. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.